Detalles de la búsqueda
1.
How I Use Next Generation Sequencing-MRD to Plan Approach and Prevent Relapse after HCT for Children and Adults with ALL.
Blood
; 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38728375
2.
Human Herpesvirus-6 Reactivation and Disease Are Infrequent in Chimeric Antigen Receptor T-cell Therapy Recipients.
Blood
; 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38635788
3.
Leukocyte transcriptome indicators of development of infection in kidney transplant recipients.
Clin Transplant
; 35(4): e14252, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33570750
4.
Association between latent proviral characteristics and immune activation in antiretrovirus-treated human immunodeficiency virus type 1-infected adults.
J Virol
; 88(15): 8629-39, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24850730
5.
Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicity.
Bone Marrow Transplant
; 2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38627450
6.
Managing side effects: guidance for use of immunotherapies in multiple myeloma.
Hematology Am Soc Hematol Educ Program
; 2023(1): 348-356, 2023 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38066898
7.
Association of Self-Reported COVID-19 Vaccination Status with COVID-19 Infection among Adult Long-Term Hematopoietic Cell Transplantation Survivors.
Transplant Cell Ther
; 29(9): 584.e1-584.e9, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37394113
8.
Next-generation sequencing-based MRD in adults with ALL undergoing hematopoietic cell transplantation.
Blood Adv
; 7(14): 3395-3402, 2023 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37196642
9.
Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL.
Blood Adv
; 7(22): 6990-7005, 2023 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37774014
10.
Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy.
Transplant Cell Ther
; 29(7): 430-437, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37031746
11.
Epidemiology of Lower Respiratory Tract Infections and Community-Acquired Respiratory Viruses in Patients with Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation: A Retrospective Cohort Study.
Transplant Cell Ther
; 28(10): 705.e1-705.e10, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35872303
12.
T cell senescence and impaired CMV-specific response are associated with infection risk in kidney transplant recipients.
Hum Immunol
; 83(4): 273-280, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35190203
13.
Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia in the Modern Era.
Transplant Cell Ther
; 28(8): 490-495, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35584783
14.
Measurable residual disease status and FLT3 inhibitor therapy in patients with FLT3-ITD mutated AML following allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant
; 56(12): 3091-3093, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34584238
15.
Use of Backup Stem Cells for Stem Cell Boost and Second Transplant in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation.
Transplant Cell Ther
; 27(5): 405.e1-405.e6, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33775587
16.
DNA Methylation Age Is More Closely Associated With Infection Risk Than Chronological Age in Kidney Transplant Recipients.
Transplant Direct
; 6(8): e576, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33134500
17.
The Frailty Risk Score predicts length of stay and need for rehospitalization after kidney transplantation in a retrospective cohort: a pilot study.
Pilot Feasibility Stud
; 5: 144, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31890257
18.
Differences in Proinflammatory Cytokines and Monocyte Subtypes in Older as Compared With Younger Kidney Transplant Recipients.
Transplant Direct
; 4(3): e348, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29707619
19.
Correction to: Measurable residual disease status and FLT3 inhibitor therapy in patients with FLT3-ITD mutated AML following allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant
; 57(4): 694, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35169285
20.
Corrigendum to "T cell senescence and impaired CMV-specific response are associated with infection risk in kidney transplant recipients" [Hum. Immunol. 83(4) (2022) 273-280].
Hum Immunol
; 83(12): 857, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36192241